NCAM1 and rheumatoid arthritis: documented rising numbers of NK (CD56+, CD3−, CD14−) cells with age in RA patients in the peripheral blood and those with current TNF-inhibition therapy (40), which demonstrated the complex factors influencing the status of NK cells.